AUSTIN, Texas–(BUSINESS WIRE)– agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced results for the third quarter ended September 30, 2022.
To read the full release, click here.
Contact for media enquiries[email protected]
Press Releases Jan 24, 2023
Diabetes Patients See Significant Benefit from Value-Based, Total Care Model, According to New Data from agilon health
Medicare Advantage patients with diabetes in the agilon model saw 2-3 times greater improvement of Hemoglobin A1c control and other measures compared to Medicare Advantage and Medicare Fee-for-Service benchmarks
Patients with diabetes with consistent Hemoglobin A1c control achieved statistically lower costs
Benefits extend to Medically Underserved Areas
AUSTIN, T.X., January 24, 2023 – agilon health, inc. (NYSE: AGL), the trusted partner empowerin...